Research and Development
About Us
News
Contact Us
More
Topmunnity Therapeutics Taiwan Limited is proud to announce today that it has become a member of the NVIDIA Inception program.
Topmunnity Therapeutics proudly announced that its AI new drug development project has been successfully selected in the 4th call for projects under the "Taipei-1" initiative, a joint effort by the Ministry of Economic Affairs and NVIDIA.
Topmunnity Therapeutics has been invited to participate in the 2025 SHIC in Boston, sharing progress in antibody and cell therapy innovation, with a focus on its AI-driven drug development platform, and engaging with international partners to explore collaboration opportunities.
_edited_edited.png){kind=small}
